Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.

Karo B, Kohlenberg A, Hollo V, Duarte R, Fiebig L, Jackson S, Kearns C, Ködmön C, Korzeniewska-Kosela M, Papaventsis D, Solovic I, van Soolingen D, van der Werf MJ.

Euro Surveill. 2019 Mar;24(12). doi: 10.2807/1560-7917.ES.2019.24.12.1800392.

2.

Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.

Sotgiu G, Falzon D, Hollo V, Ködmön C, Lefebvre N, Dadu A, van der Werf M.

PLoS One. 2017 Nov 20;12(11):e0186499. doi: 10.1371/journal.pone.0186499. eCollection 2017.

3.

Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.

de Vries G, Tsolova S, Anderson LF, Gebhard AC, Heldal E, Hollo V, Cejudo LS, Schmid D, Schreuder B, Varleva T, van der Werf MJ.

BMC Public Health. 2017 Apr 19;17(1):334. doi: 10.1186/s12889-017-4216-9.

4.

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015.

Hollo V, Beauté J, Ködmön C, van der Werf MJ.

Euro Surveill. 2017 Mar 23;22(12). pii: 30486. doi: 10.2807/1560-7917.ES.2017.22.12.30486.

5.

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.

van der Werf MJ, Hollo V, Ködmön C, Dara M, Catchpole M.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601992. doi: 10.1183/13993003.01992-2016. Print 2017 Mar. No abstract available.

6.

Multidrug-resistant tuberculosis and migration to Europe.

van der Werf MJ, Hollo V, Ködmön C.

Clin Microbiol Infect. 2017 Aug;23(8):578-579. doi: 10.1016/j.cmi.2017.02.017. Epub 2017 Feb 20. No abstract available.

7.

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.

van der Werf MJ, Ködmön C, Zucs P, Hollo V, Amato-Gauci AJ, Pharris A.

AIDS. 2016 Nov 28;30(18):2845-2853.

8.

The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.

Hollo V, Kotila SM, Ködmön C, Zucs P, van der Werf MJ.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171.

9.

Impact of HIV infection on treatment outcome of tuberculosis in Europe.

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W.

AIDS. 2016 Apr 24;30(7):1089-98. doi: 10.1097/QAD.0000000000001016.

PMID:
26752278
10.

Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W.

Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087. Erratum in: Euro Surveill. 2015;20(50). doi: 10.2807/1560-7917.ES.2015.20.50.30092.

11.

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.

van der Werf MJ, Ködmön C, Hollo V, Sandgren A, Zucs P.

Euro Surveill. 2014 Mar 13;19(10). pii: 20733.

12.

Long-term follow-up after thoracoscopic resection of solitary pulmonary tuberculoma.

Laisaar T, Viiklepp P, Hollo V.

Indian J Tuberc. 2014 Jan;61(1):51-6.

PMID:
24640345
13.

Complete republication: Epidemiology of tuberculosis in the EU/EEA in 2010 - Monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Ködmön C.

Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):292-6. doi: 10.1556/EuJMI.2.2012.4.8. Epub 2012 Dec 11.

14.

Is tuberculosis crossing borders at the Eastern boundary of the European Union?

van der Werf MJ, Hollo V, Noori T.

Eur J Public Health. 2013 Dec;23(6):1058-63. doi: 10.1093/eurpub/ckt098. Epub 2013 Jun 27.

15.

Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011.

Sandgren A, Hollo V, van der Werf MJ.

Euro Surveill. 2013 Mar 21;18(12). pii: 20431.

16.

Epidemiology of tuberculosis in the EU/EEA in 2010: monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Kodmon C.

Euro Surveill. 2012 Mar 22;17(12). pii: 20124.

17.

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.

Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1315-22. doi: 10.5588/ijtld.10.0221.

PMID:
22283887
18.

Tuberculosis and HIV co-infection in European Union and European Economic Area countries.

Pimpin L, Drumright LN, Kruijshaar ME, Abubakar I, Rice B, Delpech V, Hollo V, Amato-Gauci A, Manissero D, Ködmön C.

Eur Respir J. 2011 Dec;38(6):1382-92. doi: 10.1183/09031936.00198410. Epub 2011 Jul 7. Review.

19.

The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results.

Kruijshaar ME, Pimpin L, Abubakar I, Rice B, Delpech V, Drumright LN, Hollo V, Huitric E, van de Laar M, Amato-Gauci A, Manissero D, Ködmön C.

Eur Respir J. 2011 Dec;38(6):1374-81. doi: 10.1183/09031936.00198310. Epub 2011 Jun 30.

20.

Marking 15 years of efforts towards a comprehensive European TB surveillance system: the epidemiological situation of TB in the EU/EEA in 2009.

Hollo V, Zucs P, Ködmön C, Sandgren A, Manissero D.

Euro Surveill. 2011 Mar 24;16(12). pii: 19822. No abstract available.

21.

Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009.

Sandgren A, Hollo V, Quinten C, Manissero D.

Euro Surveill. 2011 Mar 24;16(12). pii: 19825.

22.

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.

Ködmön C, Hollo V, Huitric E, Amato-Gauci A, Manissero D.

Euro Surveill. 2010 Mar 18;15(11). pii: 19519.

23.
24.

Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us?

Hollo V, Amato-Gauci A, Kodmon C, Manissero D.

Euro Surveill. 2009 Mar 19;14(11). pii: 19151. Erratum in: Euro Surveill. 2009;14(13). pii: 19164.

25.

Multidrug-resistant tuberculosis management in resource-limited settings.

Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.

Emerg Infect Dis. 2006 Sep;12(9):1389-97.

26.

Supplemental Content

Support Center